September 11, 2009 – Abbott said yesterday it reached an $410 million agreement to purchase Evalve Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves.
September 11, 2009 – Terumo Interventional Systems yesterday launched its Glidewire Advantage Peripheral Guidewire, a single wire that enables the operator to both cross the lesion and deliver interventional devices such as balloons and stents.
September 11, 2009 – Terumo Interventional Systems yesterday announced the expansion of its Pinnacle Destination Guiding Sheaths with an 8 French size to extend the range of interventional procedures that can be performed, including atherectomy and stent graft procedures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Gregg W. Stone, M.D., offered a preview Sept. 10 of some of the key, late-breaking clinical trials and trends in interventional cardiology that will be presented during the Transcatheter Therapeutics (TCT) 2009 Symposium Sept. 21-25 in San Francisco.
September 10, 2009 – Regado Biosciences said this week it enrolled the first patient in a phase 2b, randomized, partially-blinded, multicenter, active-controlled, dose-ranging study of its REG1 anticoagulation system.
September 10, 1009 - With the details over medical imaging equipment utilization rates and Medicare reimbursement cuts for diagnostic imaging still on the table, President Obama’s televised speech on healthcare reform last night drew reaction from advocate groups like the Medical Imaging and Technology Alliance (MITA).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 10, 2009 – NI Medical Ltd. said yesterday it received FDA approval for its NICaS CS, a new device for the assessment of left ventricular systolic dysfunction (LVSD), to detect heart failure in its preclinical, asymptomatic phase.
September 9, 2009 – As September is national peripheral arterial disease (or PAD) awareness month, the Society of Interventional Radiology is highlighting recent medical research addressing the seriousness of PAD available in the libraries for interventional radiologists and primary care physicians.
The Arrow AutoCAT 2 WAVE Interaotic balloon pump (IABP) System provides counterpulsation support to the most unstable of IABP patients, those with tachyarrhythmias and variable pulse pressures, all while maintaining 1:1 assist and with full volume delivery to the catheter.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 9, 2009 – Royal Philips Electronics unveiled its PageWriter TC50 cardiograph, which uses gender-differentiated criteria to assist in the diagnosis of heart disease in women, where symptoms may be different from men. The PageWriter TC50 was launched at the European Society of Cardiology (ESC) Congress 2009 Aug. 28.
September 9, 2009 - TeraMedica Healthcare Technology, a Milwaukee-based medical informatics company, announced the USPTO granted it the U.S. patent number 7,583,861 for its Evercore Smartstore solution, a clinical data management technology.
September 9, 2009 – ProSolv CardioVascular enhanced its outcome reporting capabilities by partnering with Cedaron Medical Inc., a developer of quality measurement solutions, to provide the complete registry support that facilities need for ACC, national, and state clinical performance reporting.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 9, 2009 – Abiomed Inc. said today its percutaneous Impella ventricular assist device will be highlighted in several clinical sessions at the upcoming TCT 2009 scientific meeting Sept. 21-25, in San Francisco.
September 9, 2009 – CardiacAssist Inc. said yesterday it will exhibit its TandemHeart System in San Francisco at the TCT 2009 and will highlight speakers who have used the device in their cath labs.
September 8, 2009 – Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, said last week it received $36 million in financing to fund the European commercialization and U.S. premarket approval (PMA) clinical study of the company’s TactiCath force-sensing ablation catheter.